Charitable Lead Trusts for Pre-IPO Wealth

A founder with $12 million of pre-IPO stock wants to eventually transfer most of the value to her children while supporting charitable causes in the meantime. She funds a 10-year charitable lead annuity trust (CLAT) with the stock. The CLAT pays a charity of her choice $1.3 million per year for 10 years, then distributes the remainder to her children.

At funding, the IRS values her gift to the children (the remainder) using §7520 rate and the annuity schedule. If the §7520 rate is 4.8% and annuity is sized correctly, the remainder can be valued at or near zero for gift tax purposes. The children’s inheritance is effectively “paid for” by the charity taking the annuity stream first.

If the stock appreciates above the §7520 rate during the 10 years, the children’s eventual remainder is substantial: potentially $30M+ of value after paying $13M to charity over the decade. Estate-tax-free. Income-tax-free to the children (they receive the remainder, not income).

The CLT is the mirror image of a CRT. A CRT gives income to the donor and remainder to charity. A CLT gives income to charity and remainder to heirs. Both use the §7520 rate framework; both leverage appreciation.

The two CLT structures

CLAT (Charitable Lead Annuity Trust). Pays a fixed dollar amount annually to charity. Remainder to heirs at term end.

CLUT (Charitable Lead Unitrust). Pays a fixed percentage of annual trust value to charity. Remainder to heirs at term end.

CLATs are more common for pre-IPO wealth transfer. CLUTs work better for diversified stable portfolios.

The zeroed-out CLAT

A “zeroed-out” CLAT is structured so the remainder gift is valued at zero (or near zero) for gift tax purposes. The annuity amount is sized to achieve this.

Calculation: at the §7520 rate, the present value of the annuity stream equals the value of the contributed assets. Remainder gift is zero.

Example at 4.8% §7520 rate: to zero out a $12M contribution over 10 years:

Annuity per year × present value factor = $12M.
PV annuity factor for 10 years at 4.8% ≈ 7.79.
Annuity per year ≈ $12M / 7.79 = $1.54M.

So a 10-year CLAT with $1.54M annual annuity “zeros out” a $12M contribution at 4.8% §7520 rate.

If the stock grows at 15% per year (beating the 4.8% §7520 rate), the trust pays $15.4M to charity over 10 years and still has $25M+ of remainder for heirs.

Grantor vs non-grantor CLAT

Grantor CLAT. Grantor pays income tax on trust income during term. Grantor receives immediate charitable income tax deduction equal to the present value of the annuity stream.

Grantor pays income tax but gets upfront charitable deduction.
Remainder passes to heirs at term end, outside estate.
Favored when grantor has high income in year of funding (deduction absorbs large income event).

Non-grantor CLAT. Trust pays its own income tax; no grantor-level charitable deduction.

Trust deducts charitable distributions against its own taxable income.
Grantor gets no upfront deduction.
Favored when grantor doesn’t need the deduction or has other charitable vehicles.

Grantor CLAT is more common for founders in high-income years (pre-IPO, post-IPO, liquidity events).

Tax mechanics: grantor CLAT at funding

Grantor funds CLAT with $12M of stock, basis $1M.

Gift to children (remainder) valued at or near zero. Uses minimal lifetime exemption.
Charitable income tax deduction equal to present value of annuity stream: ~$12M (for zeroed-out CLAT).
Grantor claims $12M deduction over allowed AGI limits and carryforward years.
30% of AGI limit for contributions of appreciated property to a qualified charity.

Grantor recognizes no gain on transfer to CLAT (not a sale).

Over the 10-year term:

Trust pays $1.54M/year to charity.
Grantor pays income tax on trust income annually (grantor trust status).

At term end:

Remaining trust assets distribute to children.
No gift tax on distribution (remainder was already “gifted” at funding).
Children receive assets with carryover basis (no step-up).

The IPO catalyst

CLTs work best when funded with high-appreciation assets. Pre-IPO stock is ideal because:

Current FMV (with DLOM/DLOC discounts) is relatively low.
Post-IPO value is expected to be much higher.
IPO is a catalyst that often coincides with funding; CLT captures the step-up to liquid market value.

A founder funding a CLT 6 months before IPO at a private appraisal reflects pre-IPO discounts. If IPO occurs and stock appreciates, the entire appreciation from private valuation to public market price is captured in the CLT’s returns.

Timing consideration: funding a CLT too close to IPO raises step-transaction concerns. The IRS can argue the funding was tied to a pre-arranged disposition, disallowing the planning. Fund at least 6-12 months before any known liquidity event if possible.

The 7520 rate sensitivity

CLTs are highly sensitive to §7520 rates. Lower rates favor zeroed-out CLATs:

Lower §7520 means lower hurdle for remainder to beat.
Lower annuity amount is needed for zero-out.
More chance of large remainder to heirs.

Higher rates raise the bar. At high §7520 rates, the annuity amount to zero-out is large, and less remainder is likely.

April 2026 §7520 rate (~4.8%) is moderate. Compare to the 2% range of 2020 (very favorable for CLTs) or 5%+ rates of the 1990s (less favorable).

Comparison: CLT vs alternatives for large charitable + heir goals

Strategy	Uses exemption	Charitable deduction	Heirs receive
CLAT (zeroed-out, grantor)	Near zero	Full annuity PV	Remainder (appreciation)
CRT (non-grantor)	Potentially some	Remainder PV	Potentially zero (if charity last)
Outright charitable gift + outright heir gift	Yes (for heir gift)	Full for charity	Gift amount
Private foundation	Varies	Limited	Zero (foundation is charity)

CLTs shine when the grantor wants substantial charitable giving AND to transfer wealth to heirs with minimal exemption use.

The 10-year term choice

Most pre-IPO CLATs use 10-20 year terms. Factors:

Longer term: more compounding of appreciation above §7520 rate. More mortality risk (grantor may die during term, causing estate inclusion if grantor-status provisions trigger estate inclusion).
Shorter term: less compounding but less mortality risk. Sometimes combined with rolling.

10-year terms are common because they provide meaningful compounding while managing mortality risk for grantors under age 60.

Drafting flexibility

CLT documents can include:

Triggers for early termination upon certain events (rare; mostly just runs to term).
Provisions for changing the charitable beneficiary (must not cause the CLT to cease qualifying).
Investment policy for trustee.
Backup remainder beneficiaries if children don’t survive.

Frequently asked

Can I serve as trustee of my own CLT? Grantor as trustee can cause estate inclusion if the grantor has discretion over the charitable or remainder distributions. Independent trustee is standard.

Can I fund a CLT with private company stock that’s not publicly traded? Yes. Qualified appraisal required for the funding. DLOM and DLOC can be applied.

What if the stock declines during the term? The annuity payments to charity continue at the fixed rate (for a CLAT). Trust assets may be depleted before term end. Remainder to heirs would be zero or negative.

Do I need to pay tax on the annual annuity payments to charity? For grantor CLAT: grantor is treated as owner of trust income. Grantor may owe tax on trust’s income that is distributed to charity. This is the “double tax” grantor CLAT feature; grantor trusts pay tax on trust income. However, the charitable distribution may be deductible to the grantor annually in addition to the initial upfront deduction. Consult counsel.

Can the CLT hold employer stock with voting rights? Yes. Trustees vote the shares per the trust document and fiduciary duties.

Next step

If you have appreciating assets, charitable intent, and want to transfer to heirs, discuss CLT with your estate counsel. The §7520 rate as of funding is critical; consider timing. Engage a qualified appraiser if funding private stock. Coordinate with your income tax advisor to maximize the charitable deduction in the year of funding.